Skip to main content
Top
Published in: Annals of Hematology 1/2021

01-01-2021 | Lymphoma | Correction

Correction to: The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of pet-guided treatments

Authors: Alessia Bari, Raffaella Marcheselli, Stefano Sacchi, Alessandro Re, Chiara Pagani, Alessandra Tucci, Barbara Botto, Umberto Vitolo, Anna Lia Molinari, Benedetta Puccini, Alessandro Pulsoni, Armando Santoro, Monica Tani, Luca Nassi, Erika Meli, Vincenzo Pavone, Maurizio Bonfichi, Andrea Evangelista, Daniela Gioia, Alessandro Levis, Pierluigi Zinzani, Fondazione Italiana Linfomi (Onlus)

Published in: Annals of Hematology | Issue 1/2021

Login to get access

Excerpt

Correction to: Annals of Hematology.
Metadata
Title
Correction to: The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of pet-guided treatments
Authors
Alessia Bari
Raffaella Marcheselli
Stefano Sacchi
Alessandro Re
Chiara Pagani
Alessandra Tucci
Barbara Botto
Umberto Vitolo
Anna Lia Molinari
Benedetta Puccini
Alessandro Pulsoni
Armando Santoro
Monica Tani
Luca Nassi
Erika Meli
Vincenzo Pavone
Maurizio Bonfichi
Andrea Evangelista
Daniela Gioia
Alessandro Levis
Pierluigi Zinzani
Fondazione Italiana Linfomi (Onlus)
Publication date
01-01-2021
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 1/2021
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-020-04344-4

Other articles of this Issue 1/2021

Annals of Hematology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine